TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa- a Randomized Controlled Trial (XACT)
Brief Summary: The purpose of this study is to compare two different methods of intensified tuberculosis (TB) case finding in the community. These methods all involve the use of a mobile clinic to reach people with TB symptoms who are not able to readily access clinic services. A standard diagnostics package consisting of smear microscopy and culture (with smear result available the next day) will be compared with a novel diagnostics package involving point-of-care sputum GeneXpert MTB/RIF performed at a mobile or conventional clinic (with same day result), sputum culture, and lateral flow urinary lipoarabinomannan (LAM) testing (in HIV +ve subjects only). The primary outcome is a comparison between the number of culture +ve subjects on TB treatment in each group at the end of two months. A secondary aim is an evaluation of the accuracy and feasibility of GeneXpert performed in a mobile clinic. Additional study aims include using chest X-rays obtained during the study to develop and validate of an computer-aided diagnosis (CAD) software package for TB (together with collaborators in the Netherlands), as well as establishing whether LAM is detectable at sub-ELISA concentrations in the urine of those with TB.


Options:
A: Arm Label: GeneXpert; Type: ACTIVE_COMPARATOR; Interventions: Other: GeneXpert, Other: LED Microscopy | Arm Label: LED Microscopy; Type: ACTIVE_COMPARATOR; Interventions: Other: LED Microscopy | Intervention Type: OTHER; Name: GeneXpert; Assigned to Arm(s): GeneXpert | Intervention Type: OTHER; Name: LED Microscopy; Assigned to Arm(s): GeneXpert, LED Microscopy
B: Arm Label: Novel; Type: EXPERIMENTAL; Interventions: Procedure: GeneXpert MTB/RIF assay, Procedure: Smear microscopy | Arm Label: Standard; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Smear microscopy | Intervention Type: PROCEDURE; Name: GeneXpert MTB/RIF assay; Assigned to Arm(s): Novel | Intervention Type: PROCEDURE; Name: Smear microscopy; Assigned to Arm(s): Novel, Standard
C: Arm Label: Xpert MTB/RIF; Type: EXPERIMENTAL; Interventions: Procedure: Xpert MTB/RIF assay | Arm Label: Sputum smear microscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Smear microscopy | Intervention Type: PROCEDURE; Name: Xpert MTB/RIF assay; Assigned to Arm(s): Xpert MTB/RIF | Intervention Type: PROCEDURE; Name: Smear microscopy; Assigned to Arm(s): Sputum smear microscopy
D: Arm Label: Xpert MTB/Rif; Type: EXPERIMENTAL; Interventions: Other: Xpert MTB/Rif | Arm Label: Sputum smear; Type: ACTIVE_COMPARATOR; Interventions: Other: Smear microscopy | Intervention Type: OTHER; Name: Xpert MTB/Rif; Assigned to Arm(s): Xpert MTB/Rif | Intervention Type: OTHER; Name: Smear microscopy; Assigned to Arm(s): Sputum smear

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation After DC Cardioversion
Brief Summary: the purpose of this study is to compare the ability of propafenone and dronedarone to maintain sinus rhythm after DC cardioversion


Options:
A: Arm Label: Dronedarone 400mg bid; Type: EXPERIMENTAL; Interventions: Drug: Dronedarone (SR33589) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Dronedarone (SR33589); Assigned to Arm(s): Dronedarone 400mg bid | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
B: Arm Label: Propafenone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propafenone | Arm Label: Dronedarone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dronedarone | Intervention Type: DRUG; Name: Propafenone; Assigned to Arm(s): Propafenone | Intervention Type: DRUG; Name: Dronedarone; Assigned to Arm(s): Dronedarone
C: Arm Label: Atrial Fibrillation Ablation; Type: EXPERIMENTAL; Interventions: Procedure: Atrial fibrillation ablation | Arm Label: Drug therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Antiarrhythmic drug | Intervention Type: PROCEDURE; Name: Atrial fibrillation ablation; Assigned to Arm(s): Atrial Fibrillation Ablation | Intervention Type: DRUG; Name: Antiarrhythmic drug; Assigned to Arm(s): Drug therapy
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: 0.9% saline | Arm Label: Antazoline; Type: EXPERIMENTAL; Interventions: Drug: antazoline | Intervention Type: DRUG; Name: antazoline; Assigned to Arm(s): Antazoline | Intervention Type: DRUG; Name: 0.9% saline; Assigned to Arm(s): Placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Comprehensive Simulation-based Curriculum as a Means to Enhance Technical and Non-technical Skills in Colonoscopy: a Randomized Control Trial
Brief Summary: Colonoscopy is a commonly used medical procedure. Medical and surgical residents learning colonoscopy typically learn the procedure experientially but simulation based teaching is increasingly being integrated into training programs. The optimal manner to teach colonoscopy on virtual-reality simulators is uncertain. We aim to test a curriculum in simulation-based colonoscopy with self-directed learning on simulators.


Options:
A: Arm Label: STAC curriculum; Type: EXPERIMENTAL; Interventions: Other: STAC curriculum | Arm Label: Conventional Curriculum; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: STAC curriculum; Assigned to Arm(s): STAC curriculum
B: Arm Label: Curriculum Group; Type: EXPERIMENTAL; Interventions: Behavioral: Curriculum Group | Arm Label: Self-directed learning group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-directed learning group | Intervention Type: BEHAVIORAL; Name: Curriculum Group; Assigned to Arm(s): Curriculum Group | Intervention Type: BEHAVIORAL; Name: Self-directed learning group; Assigned to Arm(s): Self-directed learning group
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: simulator training | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: simulator training | Intervention Type: DEVICE; Name: simulator training; Assigned to Arm(s): 1, 2
D: Arm Label: Fecal occult blood testing; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Immunochemical fecal occult blood test | Arm Label: Colonoscopy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Colonoscopy | Intervention Type: PROCEDURE; Name: Immunochemical fecal occult blood test; Assigned to Arm(s): Fecal occult blood testing | Intervention Type: PROCEDURE; Name: Colonoscopy; Assigned to Arm(s): Colonoscopy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Observatoire Multicentrique Français Des Porteurs de Défibrillateur Automatique Implantable en Prévention Primaire (Cardiopathie Ischémique ou Cardiomyopathie Dilatée)
Brief Summary: The indication of implantable cardioverter defibrillator (ICD) therapy for primary prevention of sudden cardiac death has been introduced later in France than in other parts of the World. Overall, we aimed to assess the risk-benefit ratio of this strategy over a 10 year period.


Options:
A: Intervention Type: DEVICE; Name: Cardiac Resynchronization Therapy with & without defibrillator; Assigned to Arm(s): N/A
B: Arm Label: Biventricular pacing; Type: EXPERIMENTAL; Interventions: Device: Cardiac Resynchronization Therapy (CRT) | Arm Label: Right ventricular pacing; Type: ACTIVE_COMPARATOR; Interventions: Device: Cardiac Resynchronization Therapy (CRT) | Intervention Type: DEVICE; Name: Cardiac Resynchronization Therapy (CRT); Assigned to Arm(s): Biventricular pacing | Intervention Type: DEVICE; Name: Cardiac Resynchronization Therapy (CRT); Assigned to Arm(s): Right ventricular pacing
C: Arm Label: CRT OFF; Type: PLACEBO_COMPARATOR; Interventions: Device: Cardiac Resynchronization Therapy (CRT) Device or Implantable Cardioverter Defibrillator (ICD) with CRT | Arm Label: CRT ON; Type: ACTIVE_COMPARATOR; Interventions: Device: Cardiac Resynchronization Therapy (CRT) Device or Implantable Cardioverter Defibrillator (ICD) with CRT | Intervention Type: DEVICE; Name: Cardiac Resynchronization Therapy (CRT) Device or Implantable Cardioverter Defibrillator (ICD) with CRT; Assigned to Arm(s): CRT OFF, CRT ON
D: N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II, Open-label, Multicentre, Pharmacokinetic, Pharmacodynamics and Safety Study of a New Paediatric Eurartesim Dispersible Formulation and Crushed Film Coated Eurartesim Tablet, in Infant Patients With P. Falciparum Malaria
Brief Summary: There is a need for paediatric formulations that permit accurate dosing and enhance patient compliance. However, for the treatment of malaria, scarce paediatric-friendly formulations are available on the market. Thus, a new water dispersible formulation of eurartesim has been developed for oral administration.

Aim of this study is to provide data on pharmacokinetic profile, safety and efficacy of this new paediatric formulation and compare it with the crushed film coated tablet in infant patients (6 to ≤12 months of age) suffering from uncomplicated Plasmodium falciparum malaria.

Furthermore, a Pharmacokinetic/Pharmacodynamic(PK/PD) modelling will be built up to establish PK/PD relationship in adult and paediatric populations.


Options:
A: Arm Label: co-formulated Amodiaquine-Artesunate; Type: ACTIVE_COMPARATOR; Interventions: Drug: amodiaquine-artesunate (AQAS) fixed-dose | Arm Label: artemether-lumefantrine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Artemether-lumefantrine combination (AL) dispersable | Intervention Type: DRUG; Name: amodiaquine-artesunate (AQAS) fixed-dose; Assigned to Arm(s): co-formulated Amodiaquine-Artesunate | Intervention Type: DRUG; Name: Artemether-lumefantrine combination (AL) dispersable; Assigned to Arm(s): artemether-lumefantrine
B: Arm Label: Eurartesim dispersible oral tablets; Type: EXPERIMENTAL; Interventions: Drug: Eurartesim dispersible oral tablet | Arm Label: Eurartesim film coated tablet; Type: ACTIVE_COMPARATOR; Interventions: Drug: eurartesim film coated tablet | Intervention Type: DRUG; Name: Eurartesim dispersible oral tablet; Assigned to Arm(s): Eurartesim dispersible oral tablets | Intervention Type: DRUG; Name: eurartesim film coated tablet; Assigned to Arm(s): Eurartesim film coated tablet
C: Arm Label: PA group; Type: EXPERIMENTAL; Interventions: Drug: pyronaridine artesunate | Arm Label: AL group; Type: ACTIVE_COMPARATOR; Interventions: Drug: arthemeter lumefantrine | Intervention Type: DRUG; Name: pyronaridine artesunate; Assigned to Arm(s): PA group | Intervention Type: DRUG; Name: arthemeter lumefantrine; Assigned to Arm(s): AL group
D: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Artemether/lumefantrine tablets | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Artemether/Lumefantrine suspension | Intervention Type: DRUG; Name: Artemether/lumefantrine tablets; Assigned to Arm(s): A | Intervention Type: DRUG; Name: Artemether/Lumefantrine suspension; Assigned to Arm(s): B

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Telephone Symptom Management for Advanced Lung Cancer Patients and Caregivers
Brief Summary: The goal of this project is to examine the physical and psychological health benefits of a novel, telephone-delivered symptom management intervention for advanced lung cancer patients and their family caregivers.


Options:
A: Arm Label: German PRO-SELF(c) Plus PCP; Type: EXPERIMENTAL; Interventions: Behavioral: German PRO-SELF(c) Plus Pain Control Program (PCP) | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: German PRO-SELF(c) Plus Pain Control Program (PCP), Other: Standard Care | Intervention Type: BEHAVIORAL; Name: German PRO-SELF(c) Plus Pain Control Program (PCP); Assigned to Arm(s): German PRO-SELF(c) Plus PCP, Standard Care | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Psycho-educational intervention | Intervention Type: OTHER; Name: Psycho-educational intervention; Assigned to Arm(s): Intervention
C: Intervention Type: PROCEDURE; Name: management of therapy complications; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: pain therapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: psychosocial assessment and care; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: quality-of-life assessment; Assigned to Arm(s): N/A
D: Arm Label: Telephone counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone counseling | Arm Label: Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Intervention Type: BEHAVIORAL; Name: Telephone counseling; Assigned to Arm(s): Telephone counseling | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Randomized, Controlled, Superiority Study Evaluating EVARREST® Fibrin Sealant Patch Versus Standard of Care Treatment in Controlling Parenchymal Bleeding During Hepatic Surgery
Brief Summary: To evaluate the safety and hemostatic effectiveness of EVARREST® Fibrin Sealant Patch (EVARREST) versus standard of care treatment (SoC) in controlling parenchymal bleeding during hepatic surgery.


Options:
A: Arm Label: Fibrin Pad; Type: EXPERIMENTAL; Interventions: Biological: Fibrin Pad | Arm Label: Standard of Care; Type: OTHER; Interventions: Procedure: Standard of Care | Intervention Type: BIOLOGICAL; Name: Fibrin Pad; Assigned to Arm(s): Fibrin Pad | Intervention Type: PROCEDURE; Name: Standard of Care; Assigned to Arm(s): Standard of Care
B: Arm Label: TachoSil®; Type: ACTIVE_COMPARATOR; Interventions: Biological: TachoSil® | Arm Label: Surgicel® Original; Type: ACTIVE_COMPARATOR; Interventions: Device: Surgicel® Original | Intervention Type: BIOLOGICAL; Name: TachoSil®; Assigned to Arm(s): TachoSil® | Intervention Type: DEVICE; Name: Surgicel® Original; Assigned to Arm(s): Surgicel® Original
C: Arm Label: Standard Care; Type: PLACEBO_COMPARATOR; Interventions: Drug: No tranexamic acid | Arm Label: Dose 1; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid | Arm Label: Dose 2; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid | Intervention Type: DRUG; Name: No tranexamic acid; Assigned to Arm(s): Standard Care | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Dose 1, Dose 2
D: Arm Label: EVARREST® Fibrin Sealant Patch; Type: EXPERIMENTAL; Interventions: Biological: EVARREST® Fibrin Sealant Patch | Arm Label: Standard of Care (SoC); Type: OTHER; Interventions: Other: Standard of Care (SoC) | Intervention Type: BIOLOGICAL; Name: EVARREST® Fibrin Sealant Patch; Assigned to Arm(s): EVARREST® Fibrin Sealant Patch | Intervention Type: OTHER; Name: Standard of Care (SoC); Assigned to Arm(s): Standard of Care (SoC)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of Adjunctive Social Media for More Effective Contraceptive Counseling
Brief Summary: The scope of this project was to provide evidence that better contraceptive choices are made with more effective counseling as well as improvement in patients' contraceptive knowledge. Specifically we wanted to evaluate the use of social media as a means for effective patient counseling.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Daily ART-adherence SMS reminder, Behavioral: Standard Adherence Counselling/Patient experience group chat | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Adherence Counselling/Patient experience group chat | Intervention Type: BEHAVIORAL; Name: Daily ART-adherence SMS reminder; Assigned to Arm(s): Intervention group | Intervention Type: BEHAVIORAL; Name: Standard Adherence Counselling/Patient experience group chat; Assigned to Arm(s): Control group, Intervention group
B: Arm Label: Standard + Pamphlet; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Pamphlet | Arm Label: Group 2: standard + facebook; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Facebook | Intervention Type: BEHAVIORAL; Name: Facebook; Assigned to Arm(s): Group 2: standard + facebook | Intervention Type: BEHAVIORAL; Name: Pamphlet; Assigned to Arm(s): Standard + Pamphlet
C: Arm Label: 1. One way SMS messages.; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 2. Two Way SMS messages; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 3. One way automated calls.; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 4.Two way interactive automated calls; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 5. Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SMS messages and automated calls; Assigned to Arm(s): 1. One way SMS messages., 2. Two Way SMS messages, 3. One way automated calls., 4.Two way interactive automated calls
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: CHW-Visit; Type: EXPERIMENTAL; Interventions: Behavioral: Delivery of a Post-Partum Package | Arm Label: CHW-Phone; Type: EXPERIMENTAL; Interventions: Behavioral: Delivery of a Post-Partum Package | Intervention Type: BEHAVIORAL; Name: Delivery of a Post-Partum Package; Assigned to Arm(s): CHW-Phone, CHW-Visit

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Control Trial Comparing Walking Task Specific Training With Stride Management Assist (SMA) Device vs.Functional Task Specific Training on Functional Walking Ability in Outpatient Stroke Rehabilitation
Brief Summary: Hypothesis/Specific Aims:

The purpose of this study is to determine the effect of training with the Stride Management Assist (SMA) device vs. Impairment based physical therapy (IPT) on descending corticospinal drive to the lower limb muscles in patients post stroke. The investigators hypothesize that long-term SMA use would strengthen the connections between the motor areas of the brain and the lower limbs. Specifically, individuals in the SMA group will show higher corticospinal excitability of the lower limb muscles compared to those in the IPT group.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Seated Robot Training (SRT) | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: Treadmill Locomotor-based Training (TMR) | Arm Label: Arm 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treadmill Only (TMO) | Intervention Type: BEHAVIORAL; Name: Seated Robot Training (SRT); Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Treadmill Locomotor-based Training (TMR); Assigned to Arm(s): Arm 2 | Intervention Type: BEHAVIORAL; Name: Treadmill Only (TMO); Assigned to Arm(s): Arm 3
B: Arm Label: Low-Reward; Type: EXPERIMENTAL; Interventions: Device: Anklebot (Ankle Robot) | Arm Label: High-Reward; Type: ACTIVE_COMPARATOR; Interventions: Device: Anklebot (Ankle Robot) | Intervention Type: DEVICE; Name: Anklebot (Ankle Robot); Assigned to Arm(s): High-Reward, Low-Reward
C: Arm Label: Stride Management Assist (SMA) System; Type: EXPERIMENTAL; Interventions: Device: The Stride Management Assist (SMA) System | Arm Label: Impairment based therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Impairment based therapy | Intervention Type: DEVICE; Name: The Stride Management Assist (SMA) System; Assigned to Arm(s): Stride Management Assist (SMA) System | Intervention Type: OTHER; Name: Impairment based therapy; Assigned to Arm(s): Impairment based therapy
D: Intervention Type: PROCEDURE; Name: Robot-assisted gait training; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Control Trial Comparing Walking Task Specific Training With Stride Management Assist (SMA) Device vs.Functional Task Specific Training on Functional Walking Ability in Outpatient Stroke Rehabilitation
Brief Summary: Hypothesis/Specific Aims:

The purpose of this study is to determine the effect of training with the Stride Management Assist (SMA) device vs. Impairment based physical therapy (IPT) on descending corticospinal drive to the lower limb muscles in patients post stroke. The investigators hypothesize that long-term SMA use would strengthen the connections between the motor areas of the brain and the lower limbs. Specifically, individuals in the SMA group will show higher corticospinal excitability of the lower limb muscles compared to those in the IPT group.


Options:
A: Arm Label: Robot-Assisted Stair Climbing Training; Type: EXPERIMENTAL; Interventions: Device: G-EO System | Arm Label: Conventional Physiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional Physiotherapy | Intervention Type: DEVICE; Name: G-EO System; Assigned to Arm(s): Robot-Assisted Stair Climbing Training | Intervention Type: OTHER; Name: Conventional Physiotherapy; Assigned to Arm(s): Conventional Physiotherapy
B: Arm Label: Exoskeleton Program; Type: EXPERIMENTAL; Interventions: Device: Exoskeleton Program | Arm Label: Usual Care Program; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Program | Intervention Type: DEVICE; Name: Exoskeleton Program; Assigned to Arm(s): Exoskeleton Program | Intervention Type: OTHER; Name: Usual Care Program; Assigned to Arm(s): Usual Care Program
C: Arm Label: Stride Management Assist (SMA) System; Type: EXPERIMENTAL; Interventions: Device: The Stride Management Assist (SMA) System | Arm Label: Impairment based therapy; Type: ACTIVE_COMPARATOR; Interventions: Other: Impairment based therapy | Intervention Type: DEVICE; Name: The Stride Management Assist (SMA) System; Assigned to Arm(s): Stride Management Assist (SMA) System | Intervention Type: OTHER; Name: Impairment based therapy; Assigned to Arm(s): Impairment based therapy
D: Arm Label: Ekso training; Type: EXPERIMENTAL; Interventions: Device: EKso training | Arm Label: Overground training; Type: ACTIVE_COMPARATOR; Interventions: Device: EKso training | Intervention Type: DEVICE; Name: EKso training; Assigned to Arm(s): Ekso training, Overground training

Answer: C